Compass Therapeutics (CMPX) Debt Ratio (2019 - 2021)

Compass Therapeutics has disclosed Debt Ratio across 3 years of filings, most recently posting 0.11 for Q3 2021.

• Debt Ratio for Q3 2021 came in at 0.11, down 41.82% year-over-year; the trailing twelve-month figure through Sep 2021 was 0.11 (down 41.82% YoY), and the FY2020 annual result was 0.18, down 44.18% from the prior year.
• Debt Ratio came in at 0.11 for Q3 2021 at Compass Therapeutics, down from 0.16 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.32 in Q4 2019 to a low of 0.11 in Q3 2021.
• The 3-year median for Debt Ratio is 0.18 (2020), against an average of 0.19.
• Across the five-year window, Debt Ratio sank 44.18% in 2020 and sank 41.82% in 2021, its largest moves.
• Compass Therapeutics' Debt Ratio stood at 0.32 in 2019, then plunged by 44.18% to 0.18 in 2020, then sank by 40.34% to 0.11 in 2021.
• The last three Debt Ratio figures came in at 0.11 (Q3 2021), 0.16 (Q1 2021), and 0.18 (Q4 2020), per Business Quant data.